ICL Group director reports stock option holdings

ICL Group Ltd. director Yoav Doppelt has reported existing holdings of stock options over the company’s ordinary shares.

Accepted by SEC EDGAR 03/30/2026 - 06:45 PM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

ICL Group Ltd. director Yoav Doppelt has reported existing holdings of stock options over the company’s ordinary shares. One grant covers 1,055,100 underlying ordinary shares at an exercise price of $11.05 per share, expiring on March 30, 2027, and is fully vested and exercisable.

A second grant covers 1,973,684 underlying ordinary shares at an exercise price of $6.73 per share, expiring on March 6, 2030. These options vest in three equal annual installments from the March 6, 2025 grant date and are held by a trustee in Doppelt’s name.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Doppelt Yoav

Role Director

Type	Security	Shares	Price	Value
Holding	Stock Options (Right to Buy)	--	--	--
Holding	Stock Options (Right to Buy)	--	--	--

Holdings: Stock Options (Right to Buy) — 3,028,784 contracts (Direct)

Footnotes (5)

F1. The stock options are fully vested and exercisable.
F2. The stock options vest in three equal annual installments from the March 6, 2025, grant.
F3. Represents an exercise price of NIS 34.79, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
F4. The options are held by a Trustee in the name of the Reporting Person.
F5. Represents an exercise price of NIS 21.18, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

Key Figures

Underlying shares (grant 1): 1,055,100 shares Exercise price (grant 1): $11.05 per share Underlying shares (grant 2): 1,973,684 shares +2 more

5 metrics

Underlying shares (grant 1) 1,055,100 shares Ordinary shares underlying stock options at $11.05

Exercise price (grant 1) $11.05 per share Stock options expiring March 30, 2027

Underlying shares (grant 2) 1,973,684 shares Ordinary shares underlying stock options at $6.73

Exercise price (grant 2) $6.73 per share Stock options expiring March 6, 2030

Vesting schedule (grant 2) 3 equal annual installments From March 6, 2025 grant date

Key Terms

Stock Options (Right to Buy), Ordinary Shares, exercise price, vest in three equal annual installments, +1 more

5 terms

Stock Options (Right to Buy) financial

"security_title: "Stock Options (Right to Buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"Represents an exercise price of NIS 34.79, converted to U.S. dollars"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in three equal annual installments financial

"The stock options vest in three equal annual installments from the March 6, 2025, grant."

Trustee financial

"The options are held by a Trustee in the name of the Reporting Person."

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position does Yoav Doppelt report in ICL stock options?

Yoav Doppelt reports holding stock options over ICL ordinary shares. One grant covers 1,055,100 shares at $11.05 per share, fully vested and expiring March 30, 2027. A second grant covers 1,973,684 shares at $6.73 per share, expiring March 6, 2030.

Are Yoav Doppelt’s ICL stock options fully vested or subject to vesting?

One ICL option grant held by Yoav Doppelt is fully vested and exercisable. The other grant vests in three equal annual installments beginning from the March 6, 2025 grant date, meaning those options become exercisable gradually over three years.

What are the exercise prices and expirations of Yoav Doppelt’s ICL options?

Doppelt holds options with a $11.05 exercise price expiring March 30, 2027, over 1,055,100 shares. He also holds options with a $6.73 exercise price expiring March 6, 2030, over 1,973,684 shares, both referencing ICL ordinary shares as the underlying security.

How many ICL ordinary shares underlie Yoav Doppelt’s reported stock options?

His reported ICL stock options cover two blocks of ordinary shares: 1,055,100 underlying shares tied to options at $11.05 per share, and 1,973,684 underlying shares tied to options at $6.73 per share, according to the disclosed derivative holdings summary.

Who holds legal title to Yoav Doppelt’s ICL stock options?

The options are held by a trustee in the name of Yoav Doppelt. This means a trustee is the record holder, while the reporting indicates they are associated with Doppelt, consistent with the disclosure regarding trustee-held options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Doppelt Yoav

(Last)

(First)

(Middle)

C/O ICL GROUP LTD.

MILLENNIUM TOWER, 23 ARENHA ST.

(Street)

TEL AVIV

6120201

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]

3a. Foreign Trading Symbol
[ICL]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)	⁽¹⁾	03/30/2027	Ordinary Shares	1,055,100	$11.05⁽³⁾	D⁽⁴⁾
Stock Options (Right to Buy)	⁽²⁾	03/06/2030	Ordinary Shares	1,973,684	$6.73⁽⁵⁾	D⁽⁴⁾

Explanation of Responses:

1. The stock options are fully vested and exercisable.

2. The stock options vest in three equal annual installments from the March 6, 2025, grant.

3. Represents an exercise price of NIS 34.79, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

4. The options are held by a Trustee in the name of the Reporting Person.

5. Represents an exercise price of NIS 21.18, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

	/s/ Doppelt Yoav	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR